NASDAQ: BJDX - Bluejay Diagnostics, Inc.

Altı ay boyunca karlılık: +2 892.13%
Temettü getirisi: 0.00%
Sektör: Healthcare

Promosyon programı Bluejay Diagnostics, Inc.

Gelişmiş program Basit grafik
Financial Markets by TradingView

Şirket hakkında Bluejay Diagnostics, Inc.

Bluejay Diagnostics, Inc., a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis.

daha fazla ayrıntı
In addition, it develops IL-6 for the monitoring of disease progression in critical care; as well as hsTNT/I and NT-proBNP for the monitoring of patients acuity with chest pain. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.
Karşılaştırma listesine ekle
İzleme listesine ekle
Portföye ekle
Fiyat bildirimi ekle

IPO date 2021-11-10
ISIN US0956331039
Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.bluejaydx.com
Цена ао 3.73
Günlük fiyat değişimi: -1.04% (3.84)
Haftalık fiyat değişimi: -9.31% (4.19)
Aylık fiyat değişimi: -4.52% (3.98)
3 ayda fiyat değişimi: +4.97% (3.62)
Altı ayda fiyat değişimi: +2 892.13% (0.127)
Yıllık fiyat değişimi: +373.23% (0.803)
3 yılda fiyat değişimi: +211.48% (1.22)
Yılbaşından bu yana fiyat değişimi: -1.04% (3.84)
Tüm parametreler

Hafife alma

İsim Anlam Seviye
P/S 647.73 1
P/BV 0.1231 10
P/E 0 0
EV/EBITDA 0.1555 10
Toplam: 5.13

Yeterlik

İsim Anlam Seviye
ROA, % -204.45 0
ROE, % -343.85 0
Toplam: 0

Temettüler

İsim Anlam Seviye
Div yield, % 0 0
DSI 0 0
Toplam: 0

Görev

İsim Anlam Seviye
Debt/EBITDA -0.0388 10
Toplam: 10

Büyüme dürtüsü

İsim Anlam Seviye
karlılık Revenue, % 0 0
karlılık Ebitda, % 511.53 10
karlılık EPS, % 6002.75 10
Toplam: 8
Daha fazla ayrıntı

Kurumlar Hacim Paylaşmak, %
Sabby Management, LLC 149926 5.58
Armistice Capital, LLC 24230 0.9
Citadel Advisors Llc 22077 0.82
Tower Research Capital LLC (TRC) 3252 0.12
JP Morgan Chase & Company 61 0
Osaic Holdings Inc 25 0
Wells Fargo & Company 6 0



Süpervizör İş unvanı Ödeme Doğum yılı
Mr. Indranil Dey Principal Financial, Accounting & Executive Officer, President, CEO and Director 413.16k 1963 (62 yıl)
Dr. Jason Cook Chief Technology Officer 278.42k 1982 (43 yıl)
Mr. Les DeLuca Vice President of Operations N/A
Mr. Kevin Vance Chief Commercial Officer N/A 1958 (67 yıllar)
Mark W. Feinberg Chief Medical Advisor N/A
Dr. Mark W. Feinberg M.D. Chief Medical Advisor N/A

Adres: United States, Acton. MA, 360 Massachusetts Avenue - Google haritalarda aç, Yandex haritalarını aç
Web sitesi: https://www.bluejaydx.com